Greg Blanch is an Associate Director of Pricing at Eli Lilly and Company, drawing on nearly two decades of experience in the Australian pharmaceutical industry, with a focus on Health Economics and Reimbursement. Previously, Greg held key roles at AbbVie as a Market Access and Pricing Senior Manager, where they developed reimbursement strategies for oncology products, and was awarded the Presidents Award twice. Greg's past experience includes positions at Janssen, Bristol-Myers Squibb, and Astellas Pharma, ranging from analytics to marketing leadership. Greg holds multiple degrees in Chemistry, Epidemiology, Economics, and Drug Development from various universities in Australia.
This person is not in the org chart
This person is not in any teams
This person is not in any offices